India Ranbaxy shares sink after cholesterol drug recall

Shares in Indian drug giant Ranbaxy fell as much as four percent on Monday following news of a second recall of its cholesterol-busting generic drug. It was the latest blow for the New Delhi-based drugmaker, majority-owned by Japan’s Daiichi Sankyo, that is already reeling from a string of US Food and Drug Administration (FDA) import bans involving manufacturing safety worries. "The actual …
FDA News – Yahoo News Search Results

Pharmaceutical Stocks

[stock-ticker]

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us